Aptevo Therapeutics (APVO) Gross Profit (2016 - 2019)
Historic Gross Profit for Aptevo Therapeutics (APVO) over the last 5 years, with Q4 2019 value amounting to $2.9 million.
- Aptevo Therapeutics' Gross Profit changed N/A to $2.9 million in Q4 2019 from the same period last year, while for Dec 2019 it was $12.5 million, marking a year-over-year change of. This contributed to the annual value of $12.5 million for FY2019, which is 543.32% up from last year.
- Latest data reveals that Aptevo Therapeutics reported Gross Profit of $2.9 million as of Q4 2019.
- In the past 5 years, Aptevo Therapeutics' Gross Profit registered a high of $5.1 million during Q3 2019, and its lowest value of -$2.4 million during Q2 2017.
- Moreover, its 5-year median value for Gross Profit was $3.0 million (2015), whereas its average is $2.7 million.
- The largest annual percentage gain for Aptevo Therapeutics' Gross Profit in the last 5 years was 43230.29% (2017), contrasted with its biggest fall of 16497.67% (2017).
- Aptevo Therapeutics' Gross Profit (Quarter) stood at $3.0 million in 2015, then grew by 20.99% to $3.7 million in 2016, then rose by 16.56% to $4.3 million in 2017, then fell by 21.23% to $3.4 million in 2018, then dropped by 14.53% to $2.9 million in 2019.
- Its Gross Profit was $2.9 million in Q4 2019, compared to $5.1 million in Q3 2019 and $1.4 million in Q2 2019.